Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02625233 · ClinicalTrials.gov registry record · NA
Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses
A NA study of Visual Disorders, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 6
- Study locations
NCT02625233 is a NA study of Visual Disorders that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 105 participants. The trial reports 6 study locations across 5 states.
The verdict
NCT02625233, a NA study of Visual Disorders, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multi-site, dispensing, 4-visit, 2-arm parallel group, randomized, double-masked clinical trial using a Vistakon investigational contact lens (test) and a marketed monthly replacement contact lens (control). Each subject will be assigned randomly to either the test or control lens to evaluate the long term safety and efficacy of the investigational contact lens compared to the marketed contact lens over a period of six months of lens wear.
Conditions Studied
Interventions
- DEVICE senofilcon C
- DEVICE comfilcon A
Study Locations (6)
Florida
- Vue Optical Boutique - Jacksonville
- Omega Vision Center, PA / Sabal Eye Care - Longwood
Illinois
- Eyecare Associates - Bloomington
New Jersey
- Dr. Debbie H. Kim, OD - Closter
New York
- Sacco Eye Group - Vestal
Utah
- Dr. William Bogus - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2016-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02625233
The ClinicalTrials.gov registry entry for NCT02625233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Visual Disorders appearing as the primary indexed condition, and to 2 interventions - of which senofilcon C is the first listed.
NCT02625233 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Florida, Illinois, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02625233 about?
NCT02625233 is a clinical study titled "Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses". This is a multi-site, dispensing, 4-visit, 2-arm parallel group, randomized, double-masked clinical trial using a Vistakon investigational contact lens (test) and a marketed monthly replacement contact lens (control). Each subject will be assigned randomly to either the test or control lens to evalu...
What is the current status of trial NCT02625233?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2015-10-01. Estimated completion is 2016-02-01.
What conditions does trial NCT02625233 study?
This clinical trial studies the following conditions: Visual Disorders.
What interventions are being tested in trial NCT02625233?
The interventions under investigation include: senofilcon C (DEVICE), comfilcon A (DEVICE).
Who is sponsoring clinical trial NCT02625233?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02625233 being conducted?
This trial has 6 study locations across Florida, Illinois, New Jersey, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.